Chachaj Angelika, Dudka Ilona, Jeziorek Małgorzata, Sowicz Monika, Adaszyńska Agnieszka, Szuba Andrzej
Department of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, Poland.
Department of Chemistry, Umeå University, Umeå, Sweden.
Front Physiol. 2023 Apr 10;14:1099555. doi: 10.3389/fphys.2023.1099555. eCollection 2023.
Lipedema is a bilateral enlargement of the legs due to abnormal depositions of subcutaneous fat. Recent studies using lymphoscintigraphy documented that lipedema associates with lymphatic alterations. It is still not known, whether non-lipedema obesity also leads to similar lymphoscintigraphic changes within lower legs. Clinically, both, lipedema and obesity may progress to secondary lymphedema. The aim of the study was to evaluate lymphoscintigraphy of lower limbs in women with lipedema in comparison to overweight/obese women. 51 women (in the mean age of 43.3 ± 13.56) with the diagnosis of lipedema and 31 women (in the mean age of 44.7 ± 13.48) with overweight/obesity were enrolled into the study. Women in both study groups had no clinical signs of lymphedema. The groups were matched by mean volume of their legs, calculated using the formula for a truncated cone. Lymphoscintigraphy was evaluated in every women qualitatively. Body composition parameters were assessed using bioelectric impedance analysis (BIA). Lymphoscintigraphic alterations within lower extremities were similar in both, lipedema and overweight/obese groups and were present in majority of women in both study groups. The most common lymphoscintigraphic alteration in both groups were additional lymphatic vessels (in the lipedema group observed in 76.5% of patients and in the overweight/obesity group - in 93.5%). Visualization of popliteal lymph nodes and dermal backflow were observed respectively in 33% and in 5.9% in the group with lipedema and in 45.2% and in 9.7% in the overweight/obesity group. There were significant relationships between severity of lymphoscintigraphic alterations and weight, lean body mass (LBM), total body water (TBW), volume of both legs and thigh circumference in the lipedema group. Such relationships were absent in the overweight/obesity group. Our study indicates that lymphatic alterations are present before development to clinically visible secondary lymphedema in both conditions, lipedema and overweight/obesity. In majority of women from both study groups they indicate rather an overload of the lymphatic system than insufficiency. Lymphoscintigraphic alterations are similar in both groups, therefore, lymphoscintigraphy is not a diagnostic tool that might distinguish lipedema from overweight/obesity.
脂肪性水肿是由于皮下脂肪异常沉积导致的双侧腿部肿大。最近使用淋巴闪烁造影术的研究表明,脂肪性水肿与淋巴系统改变有关。目前尚不清楚非脂肪性水肿肥胖是否也会导致小腿出现类似的淋巴闪烁造影变化。临床上,脂肪性水肿和肥胖都可能进展为继发性淋巴水肿。本研究的目的是比较脂肪性水肿女性与超重/肥胖女性下肢的淋巴闪烁造影情况。51名诊断为脂肪性水肿的女性(平均年龄43.3±13.56岁)和31名超重/肥胖女性(平均年龄44.7±13.48岁)纳入本研究。两个研究组的女性均无淋巴水肿的临床体征。两组通过使用截头圆锥体公式计算的腿部平均体积进行匹配。对每位女性进行淋巴闪烁造影的定性评估。使用生物电阻抗分析(BIA)评估身体成分参数。脂肪性水肿组和超重/肥胖组下肢的淋巴闪烁造影改变相似,且两个研究组的大多数女性都存在这种改变。两组最常见的淋巴闪烁造影改变是额外的淋巴管(脂肪性水肿组76.5%的患者观察到,超重/肥胖组93.5%)。脂肪性水肿组分别有33%和5.9%的患者观察到腘窝淋巴结显影和真皮回流,超重/肥胖组分别为45.2%和9.7%。在脂肪性水肿组中,淋巴闪烁造影改变的严重程度与体重、瘦体重(LBM)、总体水(TBW)、双腿体积和大腿周长之间存在显著相关性。超重/肥胖组不存在这种相关性。我们的研究表明,在脂肪性水肿和超重/肥胖这两种情况下,在发展为临床上可见的继发性淋巴水肿之前就存在淋巴系统改变。两个研究组的大多数女性显示的是淋巴系统负荷过重而非功能不全。两组的淋巴闪烁造影改变相似,因此,淋巴闪烁造影不是区分脂肪性水肿和超重/肥胖的诊断工具。